10/31/2024 3:59 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/30/2024 8:45 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/28/2024 7:35 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/24/2024 7:30 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/15/2024 8:35 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/09/2024 8:13 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/06/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
|
10/01/2024 5:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
09/30/2024 3:53 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/24/2024 8:25 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/16/2024 5:10 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/09/2024 5:10 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/30/2024 4:00 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/28/2024 6:05 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/26/2024 7:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/07/2024 8:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2024 8:24 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/09/2024 8:29 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2024 8:11 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/01/2024 7:05 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 7:20 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/27/2024 7:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/27/2024 7:16 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/24/2024 8:20 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/21/2024 3:42 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/17/2024 4:24 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/17/2024 4:25 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
06/17/2024 4:22 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/28/2024 6:14 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/22/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
05/20/2024 3:16 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form F-1/A | |
05/20/2024 8:02 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/14/2024 8:02 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
05/07/2024 9:21 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/25/2024 3:01 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form D Notice of Exempt Offering of Securities | |
04/12/2024 3:30 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/12/2024 3:30 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B5 | |
04/10/2024 8:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/09/2024 7:32 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/08/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
04/08/2024 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
Trump’s IRS Hands Massive ‘Victory Gift’ To 401K Owners (Ad) The "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you.
A tax-free gift so powerful it could reshape the financial destinies of millions of IRA and 401(k) owners… Claim your FREE 2024 Gold Guide |
04/05/2024 8:28 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/04/2024 4:10 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
04/04/2024 3:31 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 20-F Registration statement / Annual report / Transition report | |
04/04/2024 3:37 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
02/22/2024 7:25 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
02/13/2024 12:20 PM | Gordon Ariel (Filed by) NeuroSense Therapeutics (Subject) NeuroSense Therapeutics Ltd. (Subject)
| Form SC 13G/A | |
02/13/2024 9:14 AM | Ben-Noon Alon (Filed by) NeuroSense Therapeutics (Subject) NeuroSense Therapeutics Ltd. (Subject)
| Form SC 13G/A | |
02/07/2024 8:38 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024 7:48 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/09/2024 7:49 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023 4:01 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/27/2023 4:03 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/21/2023 7:45 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/14/2023 3:30 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/14/2023 8:41 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/05/2023 2:00 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/05/2023 2:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 424B3 | |
12/05/2023 7:01 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
12/04/2023 11:15 PM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form EFFECT | |
12/04/2023 5:17 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |
11/28/2023 8:00 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form 6-K Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/21/2023 9:36 AM | NeuroSense Therapeutics (Filer) NeuroSense Therapeutics Ltd. (Filer)
| Form POS AM | |